Last weekend boxer Andreas Katzourakis won the OTX junior middleweight tournament and became the new World Boxing Association ...

Junior middleweight Andreas Katzourakis believes his days as an anonymous prospect in American boxing are numbered as he aims ...

OTX crowned its junior middleweight tournament winner as Andreas Katzourakis edged Brandon Adams by split decision in ...

BEDFORD, Mass. , Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company ...

If we're looking to avoid a business that is in decline, what are the trends that can warn us ahead of time? When ...

Certel said in its third-quarter earnings report Friday that the Phase 1 data from Omega’s lead drug, OTX-2002, in ...

Omega Therapeutics is halting work on its only clinical-stage candidate as part of a strategic refocus centered on three ...

The Phase 1 monotherapy dose escalation portion of MYCHELANGELO I was designed to evaluate the safety, tolerability, pharmacokinetics, ...

Piper Sandler analyst Edward Tenthoff lowered the firm’s price target on Omega Therapeutics (OMGA) to $4 from $9 and keeps an Overweight ...